Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
about
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal studyGPCR oligomers in pharmacology and signalingClassical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical rolesIdentification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral functionHead-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic DrugsLysergic acid diethylamide: a drug of 'use'?Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsThe Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of CivilizationPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesPreclinical models of antipsychotic drug action.Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatmentMembrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCRCentral serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?PsychedelicsG protein-coupled receptor heterocomplexes in neuropsychiatric disorders.Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats.Serotonergic hallucinogens as translational models relevant to schizophrenia.Animal models of serotonergic psychedelics.Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.Regulating prefrontal cortex activation: an emerging role for the 5-HT₂A serotonin receptor in the modulation of emotion-based actions?Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOIA Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects.Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.Ligand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization propertiesInteraction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophreniaNeuropharmacology of N,N-dimethyltryptamineClinical applications of hallucinogens: A review.The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function miceNeuroreceptor activation by vibration-assisted tunneling.5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male ratsElucidation of molecular kinetic schemes from macroscopic traces using system identification.Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia.Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice.The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerizationRescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence.
P2860
Q21134103-95A58B81-0C7B-4159-9E9C-68212FFC13A6Q21198901-293EED6C-0199-471F-8693-C7F992D2B78FQ22241778-C1591CD1-1517-4B07-BE8B-C3E1F1A972D1Q24594672-506BF96C-5CB5-4FC5-A045-5588692C028FQ24595389-506423B6-9930-45E3-BBC9-0A56D8564088Q26744729-562762E0-2372-42CC-B3B7-41F78163FFEAQ26746133-E041CE55-B786-4E19-BBA2-CEAE9930D57BQ26746137-13CD732D-6386-4F86-BDBD-A19460F398BBQ26765995-8942E1A0-5067-4BD1-9E82-2377C8181A36Q26799997-EB5C7258-188A-4F7F-9A9D-FC4C4DB453C9Q26827502-44B4FBA6-5C0A-4238-8CFF-D40A112B9692Q26852047-00ED6526-4D4F-47AA-80B1-CCC00F15F9C4Q27329683-E41E89FE-714E-470C-990A-B9E5EF156830Q28080944-326DF35F-CAAA-4E74-9568-E8EBFA26C67EQ30359998-3D80929B-5FC7-457A-81E9-0B18701BC88CQ30385233-6A253D2B-8925-49ED-87CA-267D7D8A12D3Q30391868-5D6DA4AA-4C40-42F6-938D-621882761F48Q30427074-B589ADB7-6447-411D-B97F-5D5E3BB667CAQ30444312-4FEB53E1-8FDA-49B0-96FB-68F62793EC5EQ30559794-9D805274-56F8-4BF0-ADE0-FF4F8B274A44Q30630506-D106FE84-67CC-42A7-9B97-AA8ED421A83EQ33693380-EBF57B20-FC33-4146-BBD4-CDF8CDD213ACQ33811155-E7FDF422-C21C-4C61-8327-3DA5ACCDEA17Q33843524-0710DC3B-157E-4857-AD12-86D4CB3A16ACQ34236107-2623C246-A54B-4DB6-8CFF-270D81238B9CQ34244869-23C387E4-5FFB-4A5D-9DFF-5FEB1CEA385EQ34325119-93BF61E4-4BE2-447F-A016-A27ED650732AQ34427453-D31710B0-D2C3-4B18-A63A-3B77F4A0CE8EQ34508675-E4097899-814A-402D-8499-46E65E3409EEQ34524116-763EE909-FD7E-430A-BFB9-F73108619904Q34535259-9D86E718-1B9C-4D71-8FB7-595FEF685781Q34660497-5F9E1390-FB7A-43AB-8210-4DFE2EC9B0BAQ35068582-A38649F5-6AF1-42B2-A77C-3984690842DDQ35535506-F7DCA696-EBBE-4F7D-A76B-BF7F81179210Q35894762-12CECCA7-F1AC-4193-9B8D-1369F3D32DDEQ36278388-5C45D5F9-57D1-4DCA-B0BF-26F56FFFE958Q36735985-AB27B2D0-A855-43CD-BD07-C7A7297275C7Q36852536-1F1AA305-99DC-4E3D-A3C7-4B5DB5293A90Q36935273-71F2C95B-8E99-4507-9EEB-6CFCA21142B4Q37011912-D9C0DCE2-941A-46D7-9B8D-43CBB793A5F7
P2860
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@ast
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en-gb
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@nl
type
label
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@ast
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en-gb
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@nl
prefLabel
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@ast
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en-gb
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@nl
P2093
P2860
P3181
P1433
P1476
Metabotropic glutamate mGlu2 r ...... genic 5-HT2A receptor agonists
@en
P2093
Javier González-Maeso
José L Moreno
Laura Albizu
Terrell Holloway
P2860
P3181
P356
10.1016/J.NEULET.2011.01.046
P407
P577
2011-01-27T00:00:00Z